Immune signatures of checkpoint inhibitor-induced autoimmunity—A focus on neurotoxicity

Abstract

We demonstrate profound and partly subgroup-specific immune cell dysregulation in irAE-n patients, which may guide future biomarker development and targeted treatment approaches.